Market Research Logo

Peru Pharmaceuticals and Healthcare Report Q2 2015

Peru Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for qualitycontrol will continue to make Peru an appealing destination for drugmakers. However, while thepharmaceutical and healthcare markets continue to grow, the national economy continues to struggle andits dependence on key exports will hamper overall growth in the short-term.

Headline Expenditure Projections

Pharmaceuticals: PEN4.7bn (USD1.65bn) in 2014 to PEN5.0bn (USD1.7bn) in 2015; +6.2% in localcurrency terms and +2.2% in US dollar terms. Forecast has been revised upward from Q115 based onhistoric data.


BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Peru 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Peru 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Peru 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Peru 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Peru 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Peru 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Peru 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Peru 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: GDP By Expenditure (Peru 2011-2018)
Industry Risk Reward Ratings
Americas Risk/Reward Index
Peru Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Table: MINSA's Decentralised Institutions & Institutes, 2015
Table: Healthcare Resources
Table: Healthcare Activity
Table: Healthcare Personnel
Research and Development (R&D)
Clinical Trials
Regulatory Development
Intellectual Property Regime
Counterfeit Pharmaceuticals
Trade Agreements
Pricing Regime
Table: Peruvian Watchdog of Pharmaceutical Products (Observatorio Peruano de Productos Farmacéuticos, OPPF)
Reimbursement Regime
Table: Price Components Of Two Imported Medicines In Both Private And Public Sectors
Competitive Landscape
Table: Members of ADIFAN, 2014
Recent Pharmaceutical Sector Developments
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail
Company Profile
Unimed
Hersil
Sanofi
Merck & Co
GlaxoSmithKline
Novartis
Pfizer
AstraZeneca
Teva (Corporación Medco)
Demographic Forecast
Table: Population Headline Indicators (Peru 1990-2025)
Table: Key Population Ratios (Peru 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Peru 1990-2025)
Table: Population By Age Group (Peru 1990-2025)
Table: Population By Age Group % (Peru 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report